RA0358

antibody from Oursmab
Targeting: IL1RAP C3orf13, IL-1RAcP, IL1R3
Provider product page for RA0358
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0358 - Provider product page
Provider
Oursmab
Product name
Nadunolimab (Biosimilar Reference Antibody) (IL1RAP)
Antibody type
Monoclonal
Description
Nadunolimab (also known as CAN04) is a fully human IgG1-kappa monoclonal antibody that targets the interleukin-1 receptor accessory protein (IL1RAP), a co-receptor essential for signaling of multiple pro-inflammatory cytokines in the IL-1 family (including IL-1¦Á, IL-1¦Â, IL-33, and IL-36). As an IgG1 isotype, it is designed to engage immune effector functions such as antibody-dependent cellular cytotoxicity (ADCC). By binding to IL1RAP, nadunolimab blocks cytokine-mediated signaling and may also deplete IL1RAP-expressing cells in the tumor microenvironment. It is being developed as a potential therapeutic for advanced solid tumors, with a focus on non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma, often in combination with chemotherapy.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
IL1RAP protein structure - RA0358 shown in red.